Abstracts Archive - Page 284 of 1683 - ATC Abstracts

2021 American Transplant Congress
The Role of Histone Acetylation/methylation Mediated Epigenetic Modifications in the Pathogenesis of Non-alcoholic Steatohepatitis-associated Liver Carcinogenesis
P. K. Rajan¹, U. Utibe-Abasi¹, J. D. Sanabria¹, M. Banerjee², G. Smith¹, M. S. Schade¹, J. Sanabria¹, K. Sodhi¹, S. Pierre², Z. Xie², J. I. Shapiro², J. Sanabria¹
¹Department of Surgery, Marshall University, Huntington, WV, ²Marshall Institute for Interdisciplinary Research (MIIR), Marshall University, Huntington, WV
*Purpose: Hepatocellular carcinoma (HCC) is one of the most aggressive human cancers and is characterized by an acquisition of multiple abnormal phenotypes driven by epigenetic…
2021 American Transplant Congress
Longitudinal Quality of Life Assessment in Liver Transplant – Feasibility Study and Early Results
O. M. Siddiqui, P. Polineni, A. J. Thuluvath, C. Loftus
Northwestern University, Chicago, IL
*Purpose: In addition to survival, quality of life (QoL) is critical to optimizing care in liver transplantation (LT). Although QoL is associated with clinical outcomes…
2021 American Transplant Congress
Hospital-Level Metrics and Interventions to Increase Deceased Organ Donation: A Systematic Review
M. Castillo-Angeles¹, G. Li², P. Bain³, A. Salim¹, J. T. Adler¹
¹Surgery, Brigham and Women's Hospital, Boston, MA, ²Brandeis University, Waltham, MA, ³Harvard Medical School, Boston, MA
*Purpose: The shortage of transplantable organs available for the ever-growing transplant waiting list is well-described. Efforts to ameliorate this have predominantly focused on improving processes…
2021 American Transplant Congress
Early Increases in Post-Transplant Pancreatic Enzymes Are Associated with Surgical Complications Among Pancreas Transplant Recipients
S. Parajuli, G. Leverson, B. Welch, H. Sollinger, D. Kaufman, D. Mandelbrot, J. Odorico
University of Wisconsin, Madison, WI
*Purpose: An increase in the serum concentration of pancreatic enzymes (amylase and lipase) is commonly related to an acute inflammatory process in the pancreas graft…
2021 American Transplant Congress
Donor CPR and Solid Organ Transplantation
E. Larsen¹, K. Cardoza², K. Robichaux³, A. Kumar¹, V. Bowers⁴, J. Buggs⁴
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of Tampa, Tampa, FL, ³Honors College, University of South Florida, Tampa, FL, ⁴Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: In 2010, the American Heart Association and Emergency Cardiac Care (AHA ECC) set a 10-year impact goal of doubling cardiac arrest survival by 2020.…
2021 American Transplant Congress
Outcomes of Robotic Living Donor Right Hepatectomy in Liver Transplant Recipients: A Systematic Review and Meta-analysis
E. Lincango-Naranjo¹, E. Garces-Delgado², P. Solis-Pazmino³, H. Alexander-Leon⁴, G. Restrepo-Rodas², R. Mancero-Montalvo², C. J. Ponce², R. Cadena-Semanate², R. Vargas-Cordova⁵, G. Herrera-Cevallos⁶, A. Villarreal-Juris⁷, S. Vallejo¹, C. Liu-Sanchez⁸, L. P. Prokop⁹, A. D. Guerron¹⁰, O. J. Ponce¹, D. Moris¹¹
¹Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, ²Universidad Internacional del Ecuador, Quito, Ecuador, ³Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, CA, ⁴Universidad de las Americas, Quito, Ecuador, ⁵Hospital General San Francisco IESS, Quito, Ecuador, ⁶Hospital Metropolitano, Quito, Ecuador, ⁷Universidad Central del Ecuador, Quito, Ecuador, ⁸Universidad Peruana Cayetano Heredia, Lima, Peru, ⁹Mayo Clinic Libraries, Mayo Clinic, Rochester, MN, ¹⁰Department of Surgery, Duke University, Durham, NC, ¹¹Department of surgery, Duke University, Durham, NC
*Purpose: Living donor adult-to-adult liver transplantation (LT) has emerged as a feasible alternative to deceased donors. Advances in hepatobiliary surgery have allowed the introduction of…
2021 American Transplant Congress
Impact of a “COVID-free” Pathway on Living Donor Transplantation During a Pandemic
S. Koganti, Y. Cheah, C. J. Simon, M. Tobon Lascano, J. Kim, M. E. Akoad
Lahey Hospital & Medical Center, Burlington, MA
*Purpose: COVID-19 pandemic has significantly decreased rates of organ transplantation, with most programs curtailing living donor transplantations. This has led to an increase in waitlist…
2021 American Transplant Congress
Bamlanivimab for Covid-19 in Kidney Transplant Patients
M. Y. Jan, S. El-Sayegh, M. S. Yaqub, D. P. Mishler, O. Adebiyi, M. D. Anderson, T. E. Taber, A. Sharfuddin
Nephrology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Treatment options for patients with COVID 19 have limited efficacy in reducing severity and duration of viral symptoms as well as progression to severe…
2021 American Transplant Congress
Obesity is a Risk Factor for Progression to Kidney Transplant Waitlisting After Liver Transplantation
B. Shelton¹, B. Orandi¹, K. Olthoff², E. Pomfret³, K. Forde², D. Sawinski², M. Gray¹, N. Ascher⁴, J. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²University of Pennsylvania, Philadelphia, PA, ³University of Colorado School of Medicine, Aurora, CO, ⁴University of California San Francisco, San Francisco, CA
*Purpose: Non-alcoholic steatohepatitis (NASH) has emerged as a leading cause of cirrhosis, and obesity-associated comorbid conditions, including renal disease have become more prevalent. Obesity predisposes…
2021 American Transplant Congress
Impact of Donation After Circulatory Death Donor Allografts on Outcomes Following Liver Transplantation for Cholangiocarcinoma
S. Kumar¹, S. Lin², J. D. Schold²
¹Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, ²Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH
*Purpose: Improvements in the management of extra-hepatic cholangiocarcinoma (CCA) resulted in allocation of a standardized model for end-stage liver disease (MELD) exception score for liver…